| Dr Christopher Paul Potestio, MD | |
|
1 Cooper Plaza, Camden, NJ 08103 | |
| (856) 356-4924 | |
| Not Available |
| Full Name | Dr Christopher Paul Potestio |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 1 Cooper Plaza, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558705160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA10077200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooper Anesthesia Associates Pc | 1254236672 | 162 |
| Cmc Department Of Medicine Group Pa | 2163335878 | 329 |
News Archive
The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.
According to a new AARP report, the average retail price of the most popular brand-name drugs increased by 8.3 percent in 2009 and by 41.5 percent over the past five years – rates well in excess of inflation as measured by the Consumer Price Index. At the same time, major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc., hired by employers and other health plan sponsors to negotiate lower prices from drug manufacturers, experienced record profits, in some cases increasing five-fold over the past decade.
Capital Impact Partners announced today that its 2014 fourth quarter lending to projects in underserved communities topped $45 million. Highlights of this financing included continued Capital Impact leadership in funding Federally Qualified Health Center (FQHC) projects to increase the availability of healthcare to low income residents; supporting inclusive housing growth in Detroit by closing the first loan through the organization's partnership with JPMorgan Chase & Co.; and leveraging New Markets Tax Credits (NMTC) to support a variety of projects.
XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.
› Verified 9 days ago
| Entity Name | Cooper Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447207147 PECOS PAC ID: 1254236672 Enrollment ID: O20031126000651 |
News Archive
The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.
According to a new AARP report, the average retail price of the most popular brand-name drugs increased by 8.3 percent in 2009 and by 41.5 percent over the past five years – rates well in excess of inflation as measured by the Consumer Price Index. At the same time, major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc., hired by employers and other health plan sponsors to negotiate lower prices from drug manufacturers, experienced record profits, in some cases increasing five-fold over the past decade.
Capital Impact Partners announced today that its 2014 fourth quarter lending to projects in underserved communities topped $45 million. Highlights of this financing included continued Capital Impact leadership in funding Federally Qualified Health Center (FQHC) projects to increase the availability of healthcare to low income residents; supporting inclusive housing growth in Detroit by closing the first loan through the organization's partnership with JPMorgan Chase & Co.; and leveraging New Markets Tax Credits (NMTC) to support a variety of projects.
XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.
› Verified 9 days ago
| Entity Name | Chc Pain Management Center, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538109913 PECOS PAC ID: 0648265777 Enrollment ID: O20040419000397 |
News Archive
The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.
According to a new AARP report, the average retail price of the most popular brand-name drugs increased by 8.3 percent in 2009 and by 41.5 percent over the past five years – rates well in excess of inflation as measured by the Consumer Price Index. At the same time, major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc., hired by employers and other health plan sponsors to negotiate lower prices from drug manufacturers, experienced record profits, in some cases increasing five-fold over the past decade.
Capital Impact Partners announced today that its 2014 fourth quarter lending to projects in underserved communities topped $45 million. Highlights of this financing included continued Capital Impact leadership in funding Federally Qualified Health Center (FQHC) projects to increase the availability of healthcare to low income residents; supporting inclusive housing growth in Detroit by closing the first loan through the organization's partnership with JPMorgan Chase & Co.; and leveraging New Markets Tax Credits (NMTC) to support a variety of projects.
XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.
› Verified 9 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679605554 PECOS PAC ID: 2163335878 Enrollment ID: O20050203000280 |
News Archive
The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.
According to a new AARP report, the average retail price of the most popular brand-name drugs increased by 8.3 percent in 2009 and by 41.5 percent over the past five years – rates well in excess of inflation as measured by the Consumer Price Index. At the same time, major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc., hired by employers and other health plan sponsors to negotiate lower prices from drug manufacturers, experienced record profits, in some cases increasing five-fold over the past decade.
Capital Impact Partners announced today that its 2014 fourth quarter lending to projects in underserved communities topped $45 million. Highlights of this financing included continued Capital Impact leadership in funding Federally Qualified Health Center (FQHC) projects to increase the availability of healthcare to low income residents; supporting inclusive housing growth in Detroit by closing the first loan through the organization's partnership with JPMorgan Chase & Co.; and leveraging New Markets Tax Credits (NMTC) to support a variety of projects.
XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Paul Potestio, MD 1 Federal Street, Sw 100, Camden, NJ 08103 Ph: (856) 356-4924 | Dr Christopher Paul Potestio, MD 1 Cooper Plaza, Camden, NJ 08103 Ph: (856) 356-4924 |
News Archive
The Ebola virus (EBOV), variant Makona, was the causative agent of the 2014-2016 West African epidemic that took over 11,000 lives and infected nearly 30,000 people. But with the combination of globally-supported containment efforts, health experts were able to track the spread of the outbreak, as well as use precautionary and quarantine procedures.
According to a new AARP report, the average retail price of the most popular brand-name drugs increased by 8.3 percent in 2009 and by 41.5 percent over the past five years – rates well in excess of inflation as measured by the Consumer Price Index. At the same time, major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc., hired by employers and other health plan sponsors to negotiate lower prices from drug manufacturers, experienced record profits, in some cases increasing five-fold over the past decade.
Capital Impact Partners announced today that its 2014 fourth quarter lending to projects in underserved communities topped $45 million. Highlights of this financing included continued Capital Impact leadership in funding Federally Qualified Health Center (FQHC) projects to increase the availability of healthcare to low income residents; supporting inclusive housing growth in Detroit by closing the first loan through the organization's partnership with JPMorgan Chase & Co.; and leveraging New Markets Tax Credits (NMTC) to support a variety of projects.
XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.
› Verified 9 days ago
Dr. Maria Cassotis, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 484-832-7271 | |
James M Armstrong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Our Lady Of Lourdes Medical Center, 1600 Haddon Avenue, Camden, NJ 08103 Phone: 856-757-3836 | |
Julie Mathew, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz Dept Of, Camden, NJ 08103 Phone: 856-342-2425 | |
Dr. Dejan Vuckovic, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 | |
Khalid A Hanafy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-546-8525 | |
Dennis Mcfadden, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Cooper Anethesia Associates, Camden, NJ 08103 Phone: 856-342-2425 Fax: 856-968-8239 | |
Dr. Kelly Ann Bolkus, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2425 |